FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. As active components the composition comprises 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin. Also, invention relates to a set used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism that comprises 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin for simultaneous or successive administration, to using 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin in preparing a medicinal agent used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism, to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. Method involves administration the indicated pharmaceutical composition in pharmacologically active doses in warm-blooded animals and to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism involving the simultaneous or successive administration of this composition in warm-blooded animals. Invention provides effective inhibition of thrombosis due to potentiation of effects and enhanced effectiveness in treatment of diseases caused by thrombosis and thromboembolism.
EFFECT: valuable medicinal properties of compositions.
20 cl, 2 tbl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HYDROPYRIDINE DERIVATIVE ACID ADDITIVE SALTS | 2001 |
|
RU2238275C1 |
METHOD FOR PRODUCING HIGH-PURITY PRASUGREL HYDROCHLORIDE | 2008 |
|
RU2435776C2 |
CRYSTALS OF PRASUGREL HYDROBROMATE | 2010 |
|
RU2484094C1 |
METHOD OF PRODUCING HIGHLY PURE PRASUGREL OR ACID ADDITION SALT THEREOF | 2007 |
|
RU2424243C2 |
PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2270695C2 |
PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2281757C2 |
DERIVATIVES OF TETRAHYDROTHIENO-[3,2-C]-PYRIDINE OR THEIR FURO-ANALOGS AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2089553C1 |
COMPOUND HAVING THROMBOCYTE AGGREGATION INHIBITION ACTION, AND A SALT THEREOF, AND A COMPOSITION COMPRISING SUCH COMPOUNDS FOR PREVENTING OR TREATING THROMBOTIC DISEASES | 2016 |
|
RU2739915C2 |
THIENOPYRIDINE ESTER DERIVATIVE, CONTAINING CYANOGROUP, METHOD OF ITS OBTAINING, ITS APPLICATION AND BASED ON IT COMPOSITION | 2011 |
|
RU2526624C2 |
ANTIPLATELET AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION CONTAINING THIENEPYRIDINE DERIVATIVE AND INHIBITOR OF HMG-COA-REDUCTASE | 1997 |
|
RU2176504C2 |
Authors
Dates
2005-10-27—Published
2001-12-20—Filed